As norovirus cases increase across the U.S., Moderna is conducting a phase 3 trial with 25,000 participants to test its experimental vaccine, CNBC reported.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Moderna races to create norovirus vaccines
